Akums Drugs & Pharmaceuticals Ltd. AKUMS.NS · Stock Open Akums Drugs & Pharmaceuticals Ltd. in new tab
Akums Drugs & Pharmaceuticals Ltd. Analysis (AKUMS.NS)
Is Akums Drugs & Pharmaceuticals Ltd. a good investment? Akums Drugs & Pharmaceuticals Ltd. (AKUMS.NS) is currently trading at 681.20 INR. Market analysts have a consensus price target of 690.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 39.54. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Akums Drugs & Pharmaceuticals Ltd. is expected to release its next earnings report on Aug. 7, 2026. The market consensus estimate for Forward EPS is 31.46.
For income investors, Akums Drugs & Pharmaceuticals Ltd. pays a dividend yield of 0.45%.
Investor FAQ
Does Akums Drugs & Pharmaceuticals Ltd. pay a dividend?
Yes, it pays an annual dividend of 3.00 INR (0.45% yield).
What asset class is Akums Drugs & Pharmaceuticals Ltd.?
Akums Drugs & Pharmaceuticals Ltd. is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be Aug. 7, 2026. The company currently has a trailing EPS of 16.65.
Company Profile
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
3.00 INR
|
| Aug. 9, 2026 | 3.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Akums Drugs & Pharmaceuticals Ltd. | Aug 09, 2026 | Upcoming | 3.0 INR |
Community Discussion